Skip to content

Assessment of before and after outcome of bacterial vaginosis by homoeopathic medicine in reproductive age group women comparing its effect through in- vitro

Assessment of pre and post therapeutic outcome of reproductive age group women suffering from bacterial vaginosis by individualized homoeopathic medicine comparing its effect through in- vitro analysis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066638
Enrollment
60
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis

Interventions

Intervention1: Individualised Homoeopathic medicine: A) individualised Homoeopathic medicine selected after the consultation of homoeopathic materia medica. B) homoeopathic medicines should be given i

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from symptoms of vaginal white discharge. Patient who’s satisfying the Amsel’s criteria. Patient age group 15-49 years of female, of any religion, of any socio-economic background. Patents who know and understand either Hindi or English or Bengali. Patients who are willing to give assent and/or consent. Patients who are willing to give consent for clinical examination and sample collection.

Exclusion criteria

Exclusion criteria: Patients suffering from other infectious disease like trichomoniasis, candidiasis. Patient who’s taking OCPs, who’s Pregnant and lactating. Patient who are already taking homoeopathic treatment for any other chronic disease. Patient suffering from any life threatening/ Psychiatric/ systemic illness or Immunocompromised state or other significant disease conditions. Substance abuse and/or dependence. History of antibacterial therapy within two weeks prior to their attendance. Women with genital malignancy excluded from the study

Design outcomes

Primary

MeasureTime frame
Assessment of change in the symptoms will be recorded on the basis of score either increase or decrease obtained by VSQ21 and Hay’s classification system with Nugent scoring.Timepoint: baseline and 3rd month

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Ompriya Mishra

National Institute of Homoeopathy kolkata

drompriyanih@gmail.com8240359414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026